Pharmacological and Nutritional Approaches to Metabolic Associated Fatty Liver Disease: A Step Towards Achieving SDG 3

311
Total downloads
5,024
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 25 Nov 2025

SLC11A1 protein as a key regulator of iron metabolism, ferroptosis mediator, and putative therapeutic target in nonalcoholic fatty liver disease: an integrated bioinformatics analysis

Yang Wang
Bugao Zhou
Shanshan Li
Linxin Zheng
Xiongfeng Huang
Huiyu Wang
Sili Li
Yuhan Lin
Yanhe Xu

doi 10.3389/fphar.2025.1715699

254 views

ORIGINAL RESEARCH

Published on 04 Nov 2025

Oral administration of the probiotic strain Lactobacillus helveticus BGRA43 reduces high-fat diet–induced hepatic steatosis in mice and restores gut microbiota composition

Ana Teofilović
Miloš Vratarić
Biljana Bursać
Ljupka Gligorovska
Danijela Vojnović Milutinović
Nemanja Stanisavljević
Ivana Strahinić
Danijela Mišić
Filip Nikolić
3 more
Ana Djordjevic

doi 10.3389/fphar.2025.1688777

886 views

SYSTEMATIC REVIEW

Published on 29 Oct 2025

Association between thyroid function and metabolic associated fatty liver disease: a systemic review and meta-analysis

Wei Xiong
Hua Fan
Jiake Tang
Qingwen Yu
Ziyi Xin
Ting Tang
Xiyun Rao
Lanlan Feng
Yongmin Shi
4 more
Wentao Gan

doi 10.3389/fendo.2025.1660437

952 views

ORIGINAL RESEARCH

Published on 01 Oct 2025

Sugar-sweetened beverage consumption predicts metabolic associated fatty liver disease in patients with type 2 diabetes mellitus

Zhenjun Yu
Mengdie Chen
Shicheng Gu
Chaohui Wang
Ping Feng
Gang Lin

doi 10.3389/fendo.2025.1651370

1,663 views

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Gastrointestinal and Hepatic Pharmacology

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

5,024Topic views
3,735Article views
311Article downloads